Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.
about
Prognostic role of survivin in bladder cancer: a systematic review and meta-analysisNon-steroidal anti-inflammatory drugs in the treatment of genitourinary malignancies: focus on clinical data.Coordinated increased expression of Cyclooxygenase2 and nuclear factor κB is a steady feature of urinary bladder carcinogenesisCyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma.Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.Regulation of the prostaglandin pathway during development of invasive bladder cancer in miceRole of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies.Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer.Study of arachidonic Acid pathway in human bladder tumor.Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.Chronic inflammation in urothelial bladder cancer.Inflammatory microenvironment in the initiation and progression of bladder cancer.Non-invasive detection of bladder cancer via expression-targeted gene delivery.Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase-2 inhibitor.Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder.
P2860
Q27028122-20E55C7A-CD79-41DF-A342-7BF8A1071812Q33304363-D732D502-50E4-4EB5-9C5B-B14C9FF5D838Q34106055-92A5B757-4A18-429F-B9A2-F097F4360DBCQ35081466-176FA756-E0B7-4114-B073-9C6C488CE4CAQ36232504-C5814EBE-0079-4752-BD21-CEA840A631F9Q37041680-8E1FB97D-068A-4CC0-B658-B3572A726CDEQ37202773-089A4873-7253-45E0-B8BD-C47196F46A5EQ38027501-8B3CF4F0-3F47-47EB-A777-35FC32781617Q38172928-3C5E46DC-CEF5-4E1A-9AA2-827246672E0DQ38413564-C3F9AE43-6D92-44C1-BD44-F91D175BFA02Q38564597-045D1A89-308E-4D2D-BF24-F4BC3FDA74ADQ46779353-4935DB3E-AF76-406E-BAD2-2C093A0F818AQ47901349-91091F31-3B27-42BA-B897-33434902C462Q50848306-81BB61E3-3653-457B-BC56-0A4AE2DB4C95Q51738913-3625F228-255A-4DCF-A3D5-7C91EEFF3517Q53093929-9B49F909-A885-455A-B80C-54EA2028D103
P2860
Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Expression of cyclooxygenase-2 ...... nal cell carcinoma of bladder.
@en
type
label
Expression of cyclooxygenase-2 ...... nal cell carcinoma of bladder.
@en
prefLabel
Expression of cyclooxygenase-2 ...... nal cell carcinoma of bladder.
@en
P2093
P1476
Expression of cyclooxygenase-2 ...... nal cell carcinoma of bladder.
@en
P2093
Arthur I Sagalowsky
Jer-Tsong Hsieh
Melissa Thompson
Raheela Ashfaq
Shahrokh F Shariat
Vitaly Margulis
P304
P356
10.1016/J.JURO.2006.10.033
P407
P50
P577
2007-03-01T00:00:00Z